Big Pharma’s at it again, and the stench of their latest schemes could wake a coma patient. Post-2025, they’re doubling down on vaccine mandates and jacking up drug prices, all while cozying up to governments they’ve got in their pocket. Think new mRNA shots for every flu variant under the sun, pushed with the subtlety of a sledgehammer, while insulin prices soar to levels that’d make a mob boss blush. The FDA’s rubber-stamping these moves faster than you can say “conflict of interest,” with ex-Pharma execs now littering their ranks. It’s not about health—it’s about control and cash, and the little guy’s left footing the bill or facing the needle.

The collusion runs deep. Look at the 2025 lobbying spend—Pharma shelled out $350 million to sway Congress, per OpenSecrets, ensuring bills like the “Vaccine Access Act” mandate shots for schoolkids while shielding companies from liability. Meanwhile, drug price hikes are hitting record highs; a Kaiser Family Foundation report shows a 15% jump in 2025 alone, with cancer drugs leading the pack. Why? Because they can—patent laws, extended by their D.C. puppets, let them milk monopolies for decades. And don’t forget the revolving door: former CDC head Julie Gerberding joined Merck’s board, ensuring the feds play ball. It’s a rigged game, and while Pharma rakes in billions, the average American’s stuck choosing between meds and groceries.

The hypocrisy’s galling. The left, who scream about corporate greed, are silent when it’s their Big Pharma donors pulling the strings—Biden’s 2024 campaign took $5 million from Pfizer alone. They’ll push “health equity” while ignoring how these mandates and prices hit the poor hardest, forcing compliance or bankruptcy. Conservatives aren’t saints either, but at least some, like Rand Paul, are calling out the cronyism. The agenda’s clear: Pharma wants a world where every citizen’s a lifelong customer, and they’ve got the government muscle to make it happen. Wake up—this isn’t about saving!